La Jolla Pharmaceutical Company LJPC
$ 6.2
0.0%
Quarterly report 2022-Q2
added 08-15-2022
Country |
USA |
IPO year |
1994 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. George Tidmarsh |
Employees in the company |
90 |
Shares |
27.4 M |
Market Cap[1] |
$ 154 M |
EBITDA (LTM) |
$ 1.73 M |
P/E (LTM) |
8.99 |
P/S (LTM) |
3.07 |
EPS (LTM) |
0.69 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.